aTyr Pharma, Inc. (ATYR)
NASDAQ: ATYR · Real-Time Price · USD
2.990
-0.050 (-1.64%)
At close: Nov 20, 2024, 4:00 PM
2.931
-0.059 (-1.97%)
After-hours: Nov 20, 2024, 4:50 PM EST
aTyr Pharma Stock Forecast
Stock Price Forecast
The 4 analysts with 12-month price forecasts for aTyr Pharma stock have an average target of 19.25, with a low estimate of 9.00 and a high estimate of 35. The average target predicts an increase of 543.81% from the current stock price of 2.99.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for aTyr Pharma stock from 4 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Aug '24 | Sep '24 | Oct '24 | Nov '24 |
|---|---|---|---|---|
| Strong Buy | 1 | 2 | 2 | 2 |
| Buy | 1 | 1 | 2 | 2 |
| Hold | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 |
| Total | 2 | 3 | 4 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $35 | Strong Buy | Reiterates | $35 | +1,070.57% | Oct 29, 2024 |
| Wells Fargo | Wells Fargo | Buy Initiates $17 | Buy | Initiates | $17 | +468.56% | Oct 4, 2024 |
| Jefferies | Jefferies | Strong Buy Initiates $9 | Strong Buy | Initiates | $9 | +201.00% | Sep 5, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $35 | Strong Buy | Reiterates | $35 | +1,070.57% | Aug 15, 2024 |
| RBC Capital | RBC Capital | Buy Reiterates $16 | Buy | Reiterates | $16 | +435.12% | Aug 14, 2024 |
Financial Forecast
Revenue This Year
251.80K
from 353.00K
Decreased by -28.67%
Revenue Next Year
5.43M
from 251.80K
Increased by 2,057.69%
EPS This Year
-0.93
from -0.94
EPS Next Year
-0.80
from -0.93
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 525,000 | 25.6M | 171.9M | ||
| Avg | 251,797 | 5.4M | 65.5M | ||
| Low | n/a | n/a | n/a |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 48.7% | 10,086.0% | 3,063.8% | ||
| Avg | -28.7% | 2,057.7% | 1,106.0% | ||
| Low | - | - | - |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -0.89 | -0.68 | 0.69 | ||
| Avg | -0.93 | -0.80 | -0.35 | ||
| Low | -0.93 | -0.96 | -1.26 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.